Amer Zeidan, MBBS, MHS is an Associate Professor of Medicine (Hematology). Dr. Zeidan completed a hematology/oncology fellowship and a clinical research fellowship in myelodysplastic syndromes (MDS) at Johns Hopkins University where he also earned a Master of Health Science (MHS) degree in Clinical Investigation. He received his MBBS degree from the Faculty of Medicine, University of Jordan, Amman, Jordan before completing his internal medicine residency at Rochester General Hospital, Rochester, NY. Dr. Zeidan specializes in the management of MDS and acute myeloid leukemia (AML). He is a nationally and internationally recognized expert in the clinical management of myeloid malignancies. Dr. Zeidan is the principal investigator on several investigator-initiated, cooperative group, and industry sponsored clinical trials in MDS, AML, and other hematologic malignancies. Dr. Zeidan focuses on the use of immunotherapy, especially combination-based approaches for myeloid malignancies.
In this webinar, Dr. Amer Zeidan from Yale Cancer Center will discuss research most relevant to patients reported over the past year on the biology and treatment on MDS and AML. These studies were presented at the American Society of Hematology (ASH) 2019 meeting in Orlando, Florida.
Research findings are explained along with the potential impact of this research on understanding and treating MDS and AML. Participants will have the opportunity to ask Dr. Zeidan questions.
Aplastic Anemia and MDS International Foundation
4330 East West Highway | Suite 230 | Bethesda, MD 20814
Have Questions? Contact us at firstname.lastname@example.org or 800-747-2820 and press 2 for Patient Services.